Clinical experience of ¹²³I-IMP scintigraphy in detecting vertebral bone metastases of hepatocellular carcinoma

References

• Chakravorty R. C., Makoui C. Symptomatic bone metastases from occult primary liver cancer. Dig. Dis. 1977; 22: 471
   Google Scholar
• Citrin D. L., Besssent R. G., Greig W. R. A comparison of the sensitivity and accuracy of the 99mTc-phosphonate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin. Radiol. 1977; 28: 107
   Google Scholar
• Cohen M. B., Saxton R. E., Lake R. R., et al. Detection of malignant melanoma with iodine-123 iodoamphetamine. J. Nucl. Med. 1988; 29: 1200
   Google Scholar
• Ell P. J., Cellum I., Donaghy M., Lui D., Jarritt P. H., Harrison M. J. G. Cerebral blood flow studies with 1–123-iodine labelled amines. Lancet 1983; ii: 1348
   Google Scholar
• Fogelman I., Maisey M. N. Bone. An atlas of clinical nuclear medicine, I. Fogelman, M. N. Maisey. Martin Dunitz, London 1988; 1
   Google Scholar
• Gilbert H. A., Kagan A. R., Nussbaum H., et al. Evaluation of radiation therapy for bone metastases. Pain relief and quality of life. AJR 1977; 129: 1095
   PubMed Web of Science ®Google Scholar
• Hank G. W. Drug treatment for relief of pain due to bone metastases. J. Roy. Soc. Med. 1985; 78(S-9)26
   Google Scholar
• Hill T. C., Holman B. L., Lovett R., et al. Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl-123I-p-iodoamphetamine. Concise communication. J. Nucl. Med. 1982; 23: 191
   PubMedGoogle Scholar
• Holman B. L., Zimmerman R. E., Schapiro J. R., Kaplan M. L., Jone A. G., Hill T. C. Biodistribution and dosimetry of N-isopropyl-p-(123I)-iodoamphetamine in the primate. J. Nucl. Med. 1983; 24: 922
   Google Scholar
• Ishizu H., Amuro Y., Fujita S., et al. A clinico-pathological study on bone metastases in the autopsied case with hepatocellular carcinoma. (In Japanese). Acta Hepatol. Jpn. 1976; 17: 47
   Google Scholar
• Kotani K., Takahashi S., Ichiji M., Ito K., Kamogawa M., Tanaka H. A case report. Hepatocellular carcinoma with clavicle metastasis. (In Japanese). Seikeigeka To Saigaigeka 1983; 31: 669
   Google Scholar
• Kuhl D. E., Barrio J. R., Huang S. C., et al. Quantifying local cerebral blood flow by N-isopropyl-p-(123I)-iodoamphetamine tomography. J. Nucl. Med. 1982; 23: 196
   PubMedGoogle Scholar
• Kuhlman J. E., Fishman E. K., Leichner P. K., Magid D., Order S. E., Siegelman S. S. Skeletal metastases from hepatoma. Frequency, distribution, and radiographic features. Radiology 1986; 160: 175
   Google Scholar
• Kurooka N., Tokumoto Y., Ito J., et al. Two cases of bone metastases from primary hepatoma. (In Japanese). Jpn. J. Clin. Radiol. 1984; 29: 131
   Google Scholar
• Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan. Acta Hepatol. Jpn. 1991; 32: 1138, Report 9. (In Japanese)
   Google Scholar
• Livraghi T., Festi D., Monti F., Salmi A., Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161: 309
   PubMed Web of Science ®Google Scholar
• Magistretti P. L., Uren R. F., Royal H. D., Parker J. A., Front D., Kolodny G. M. N-isopropyl-123I-p-iodoamphetamine imaging in epilepsy. Functional radionuclide imaging of the brain, P. L. Magistretti. Raven Press, New York 1983; 247
   Google Scholar
• Matsuda H., Gyobu T., Ii M., Hisada K. Iodine-123 iodoamphetamine brain scan in a patient with auditory hallucination. J. Nucl. Med. 1988; 29: 558
   PubMed Web of Science ®Google Scholar
• Michael J. B., Morton A. S., Giora M., Roger L. D. Hepatocellular carcinoma. Presentation with vertebral metastases and radicular compression. Cancer 1972; 30: 202
   Google Scholar
• Nishizawa T., Higa T., Kuroda Y., Sano A., Murakami M., Takahashi Y. Increased accumulation of N-isopropyl-(I-123)p-iodoamphetamine in bronchial carcinoid tumor. J. Nucl. Med. 1990; 31: 240
   Google Scholar
• Ono S., Fukunaga M., Otsuka N., et al. Visualization of lung metastatic lesion from malignant melanoma by N-isopropyl-p-123I-iodoamphetamine. Usefulness of L-DOPA load scintigraphy. (In Japanese). Jpn. J. Nucl. Med. 1987; 24: 1019
   Google Scholar
• Oyamada H., Terui S., Uehara T., Fukuma H. Studies on the abnormal accumulations in vertebrae found on the bone scintigram in cancer patients. (In Japanese). Radioisotope 1980; 29: 15
   Google Scholar
• Pistenma D. A., McDougall I. R., Kriss J. P. Scanning for bone metastases. Are only scans necessary?. JAMA 1975; 231: 46
   PubMed Web of Science ®Google Scholar
• Sakata K., Hirai K., Hiratsuka Y., et al. A case of hepatocellular carcinoma metastatic to the left humerus with survival for 6 years and 9 months. (In Japanese). Acta Hepatol. Jpn. 1991; 32: 79
   Google Scholar
• Sharp P., Gemmell H., Cherryman G., Besson J., Crawford J., Smith F. Application of iodine-123-labeled isopropylam-phetamine imaging to the study of dementia. J. Nucl. Med. 1986; 27: 761
   PubMedGoogle Scholar
• Suto Y., Ishii Y., Caner B. E., Noguchi M., Katsube Y., Torizuka K. Increased iodine-123-iodoamphetamine uptake in hepatoma. Radiat. Med. 1989; 7: 274
   Google Scholar
• Szasz I. J., Lyster O., Morrison R. T. Iodine-123-IMP uptake in brain metastasis from lung cancer. J. Nucl. Med. 1985; 26: 1342
   Google Scholar
• Tahara T., Ichiya Y., Kuwabara Y., Otuka M., Masuda K. Comparison of bone, gallium and hepatobiliary scintigraphy in the detection of bone metastases in hepatoma. (In Japanese). Jpn. J. Nucl. Med. 1988; 25: 1337
   Google Scholar
• Takahashi H., Wands J. R. Prognosis of hepatocellular carcinoma. Known to be poor: yet difficult to predict. J. Nucl. Med. 1991; 32: 235
   Google Scholar
• Thomas A. F., Robertson M. M., Gottschals F. Hepatoma presenting as a bone tumor. S. Afr. Med. J. 1977; 52: 899
   Google Scholar
• Tisdale P. L., Collier B. D., Isitman A. T., Hellman R. S., Reif L. J. Photon deficient bone metastasis of hepatocellular carcinoma with avid gallium-67 uptake. J. Nucl. Med. 1985; 26: 1415
   Google Scholar
• Wada M., Ichiya Y., Katsuragi M., et al. Scintigraphic visualization of human malignant melanoma with N-isopropyl-p-(123I)-iodoamphetamine. Clin. Nucl. Med. 1985; 10: 415
   Google Scholar
• Winchell H. S., Baldwin R. M., Lin T. H. Development of I-123-labeled amines for brain studies. Localization of I-123 iodophenylalkyl amines in rat brain. J. Nucl. Med. 1980; 21: 940
   PubMedGoogle Scholar
• Yamada R., Sato M., Kawabata M., Nakamura K., Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397
   PubMed Web of Science ®Google Scholar